baber/WOPTO huggingface dataset:
Patent SG-172501-A1 (SG)
Title: Optical limiting with nanohybrid composites
Filed: 2009-12-28
Abstract: A nanohybrid composite for use as an optical limiter, the composite comprises afirst component selected for its giant two-photon absorption (TPA), and a secondcomponent selected for its metallic properties to reinforce nonlinear scatteringinduced by nanosecond laser pulses and to greatly enhance TPA through itssurface plasmon.FIGURE 1(C)
Patent SG-177014-A1 (SG)
Title: Dynamic channel quality measurement procedure for adaptive modulation and coding techniques
Inventor: TERRY STEPHEN E
IPC: H04L12/56
Filed: 2002-04-15
Abstract: DYNAMIC CHANNEL QUALITY MEASUREMENT PROCEDURE FORA wireless digital communication method for communicating between abase station and a plurality of user equipment mobile terminals (UEs) and employsadaptive modulation and coding (AM&C) to achieve improved radio resourceutilization and provide optimum data rates for user services. Blocks of downlink(DL) data are received by the base station which requests downlink DL channelquality measurements only from those mobile terminals (UEs) with pendingdownlink transmissions. The UEs respond to the request by measuring andreporting DL channel quality to the base station, which then allocates resourcessuch that the UEs will make best use of radio resources. The base station notifiesthe UEs of the physical channel allocation indicating fee modulation/coding rateand allocated slots followed by transmission of blocks of downlink data which aretransmitted to the UEs.Fig. 1.
Patent SG-182015-A1 (SG)
Title: Method and system for protecting intellectual property in software
Inventor: YUN TA CHUN
Filed: 2010-12-14
Abstract: METHOD AND SYSTEM FOR PROTECTING INTELLECTUAL PROPERTY IN SOFTWAREAbstractA system and method for modifying material related to computer software. The system receives an original disclosure for a software system. A masquerading algorithm is applied to the original disclosure to generate a new disclosure. The subject matter of new disclosure is different from the orginal disclosure but has the same functionality. The system also receives original source code for the software system and applis a camouflaging algorithm to the original source code to generate modified source code and conversion data for converting between the modified source code and the original source code.Figure 2.
Patent WO-2011102808-A1 (WO)
Inventor: GOEL SANKET
IPC: C12N9/12
Filed: 2011-02-21
Abstract: The invention provides for sequencing a nucleic acid molecule based on the detection of base incorporation by the release of pyrophosphate (PPi) using a new enzyme system comprising adenosine diphosphate (ADP)-glucose pyrophosphorylase (AGPase) and its substrate ADP-glucose.
Patent SG-175562-A1 (SG)
Title: Device and method for treating ballast water with uv-radiating means and catalysts.
Inventor: DAVID STENMAN
Filed: 2007-09-25
Abstract: DEVICE AND METHOD FOR TREATING BALLAST WATER WITH UV RADIATING MEANS AND CATALYSTSA device and method for treating ballast water, comprising an enclosure having LJV radiating means, and catalysts comprise a number of plates having turbulence and mixing generating means characterised in that said catalyst plates are arranged in said enclosure, and that the catalysts having turbulence and mixing generating means selected from one or more of the means from the group consisting of perforations, holes, punchings, structured pressings, corrugations, and grooves. The invention also concerns a system for treating ballast water in a ship and the use of said system.Fig. 2
Patent SG-175927-A1 (SG)
Title: Method of controlling the production of silver chloride on a silver catalyst in the production of alkylene oxides
Inventor: HENSTOCK WILLIAM
Filed: 2010-12-21
Abstract: A plant and process for producing alkylene oxides to control the production of silver chloride on a high efficiency silver catalyst is disclosed and described. The process involves reacting an alkylene and an organic chloride gas phase promoter with oxygen over the high efficiency silver catalyst. The sulfur concentration in the alkylene oxide reactor feed is controlled to reduce the production of silver chloride which acts as a catalyst poison.
Patent SG-192313-A1 (SG)
Title: Particle removal method and composition
Inventor: MARK JONATHAN BECK
Filed: 2008-02-07
Abstract: PARTICLE REMOVAL METHOD AND COMPOSITIONA method and cleaning solution for cleaning electronic substrates, such as a semiconductor wafers, hard disks, photomasks or imprint molds. The method comprises the steps of contacting a surface of the substrate with a cleaning solution comprised of a polyphosphate, and then removing the cleaning solution from the surface. Additional optional steps include applying acoustic energy to the cleaning solution while the cleaning solution is in contact with the surface, and removing the cleaning solution from the surface by rinsing the surface with a rinsing solution with or without the application of acoustic energy. The cleaning solution comprises a polyphosphate, such as any of the water soluble polyphosphates. Depending on the application, the cleaning solution may also comprise a base and/or a quantity of suspended particles. Complexing agents, amines, biocides, surfactants and/or other substances, may also be added to the cleaning solution.Fig. 1
Patent SG-178930-A1 (SG)
Title: Therapeutic dll4 binding proteins
Inventor: BENATUIL LORENZO
Filed: 2010-08-27
Abstract: Improved DLL4 binding proteins are described, including antibodies, CDR-grafted antibodies, human antibodies, and DLL4 binding fragments thereof, proteins that bind DLL4 with high affinity, and DLL4 binding proteins that neutralize DLL4 activity. The DLL4 binding proteins are useful for treating or preventing cancers and tumors and especially for treating or preventing tumor angiogenesis, and/or other angiogenesis-dependent diseases such as ocular neovascularization, or angiogenesis-independent diseases characterized by aberrant DLL4 expression or activity such as autoimmune disorders including multiple sclerosis.
Patent SG-185221-A1 (SG)
Title: Transceiver station for forming a telecommunications network node and associated telecommunications method
Inventor: HETHUIN SERGE
Filed: 2012-04-16
Abstract: Transceiver station for forming a telecommunications network node and associated telecommunications method The invention relates to a transceiver station (1) for forming a telecommunications network node, said station comprising at least two transceiver radio modules (3, 4, 5) and a control module (2) and wherein:each transceiver module is adapted to operate alternatingly as an "subscriber" station and as a base station, as a function of commands from the control module,the control module is adapted to determine a modification of the state of the network and to dynamically control at least one change in the operation of at least one transceiver module, from "subscriber" station to base station or vice versa, as a function of at least the determined modification;characterized in that the control module is adapted so that the number of "subscriber" stations connected to a base station is at most equal to 1.Figure 2
Patent SG-194252-A1 (SG)
Title: A lancet
Inventor: PATRICK YI
Filed: 2012-04-20
Abstract: The invention relates to a lancet for performing an incision. The lancet has a blade for providing an incision and a trigger housed in a housing. The trigger has a first trigger arm, a second trigger arm and a flexible member connected to the second trigger arm. A resilient member may be disposed within the housing in a pre-cutting state in which it stores energy and arranged to exert a force for moving the second trigger arm and the blade from a first stowed position through a cutting position and to a second stowed position.[FIG. 1]
Patent SG-184495-A1 (SG)
Title: External skin preparation
Inventor: SATOU KOUJI
Filed: 2011-04-07
Abstract: - 44 -AbstractA compound having a good whitening action as well as stability, an interaction with a base material for a composition for external use, and the like is searched for, and a composition for external use on skin containing the compound is provided. The composition for external use on skin contains a compound represented by the following formula (1):ORHO (1 ) (wherein R represents an alkyl group having 1 to 8 carbon atoms).
Patent SG-186782-A1 (SG)
Title: Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
Inventor: HOLDEN BRIEN ANTHONY
Filed: 2011-07-01
Abstract: The invention provides a use of panthenol or dexpanthenol in the prevention and/or treatment of contact lens papillary conjunctivitis in a subject. A contact lens care solution containing 0.001 to 10% by dry weight dexpanthenol is also provided.
Patent SG-195480-A1 (SG)
Title: Cross flow manifold for electroplating apparatus
Inventor: ABRAHAM RICHARD
Filed: 2013-05-13
Abstract: CROSS FLOW MANIFOLD FOR ELECTROPLATING APPARATUS[176] The embodiments herein relate to methods and apparatus for electroplating one ormore materials onto a substrate. In many cases the material is a metal and the substrate is a semiconductor wafer, though the embodiments are no so limited. Typically, the embodiments herein utilize a channeled plate positioned near the substrate, creating a cross flow manifold defined on the bottom by the channeled plate, on the top by the substrate, and on the sides by a cross flow confinement ring. During plating, fluid enters the cross flow manifold both upward through the channels in the channeled plate, and laterally through a cross flow side inlet positioned on one side of the cross flow confinement ring. The flow paths combine in the cross flow manifold and exit at the cross flow exit, which is positioned opposite the cross flow inlet. These combined flow paths result in improved plating uniformity.FIG. 3A
Patent SG-190659-A1 (SG)
Title: Adherent cells from placenta tissue and use thereof in therapy
Inventor: MEIRON MORAN
IPC: A61K35/12
Filed: 2009-09-01
Abstract: A method of culturing adherent cells from a placenta or adipose tissue is disclosed. The method comprising culturing the adherent cells from the placenta oradipose tissue under 3 dimensional (3D) culturing conditions which allow cellexpansion, the conditions comprising perfusion.No suitable figure 5 6-8A method of culturing adherent cells from a placenta or adipose tissue is disclosed. The method comprising culturing the adherent cells from the placenta or adipose tissue under 3 dimensional (3D) culturing conditions which allow ce 10 expansion, the conditions comprising perfusion.
Patent SG-191178-A1 (SG)
Title: Elastomeric nanocomposites, nanocomposite compositions, and methods of manufacture
Inventor: WENG WEIQING
Filed: 2011-12-06
Abstract: An elastomeric nanocomposite contains: (a) at least one elastomer comprising units derived from isoolefins having from 4 to 7 carbon atoms; (b) at least 10 phr of a carbon black; and (c) at least 1 phr of a nanoclay; wherein when the nanocomposite is used in an article, the article has a gas permeation coefficient of 80.0 cc*mm/[m2-day] at 40° C. The carbon black may be graphitized to reduce interactions between the carbon black and the nanoclays. The elastomeric nanocomposite may, with or without the use of the graphitized carbon black, may calendared or extruded in such a manner as to orient the nanoclay platelets within the composition such that the oriented nanoclay elastomer nanocomposite has an orientation parameter of greater than 0.15.
Patent SG-191926-A1 (SG)
Title: Combinations
Inventor: AUGER KURT R
Filed: 2012-01-26
Abstract: The present invention relates to a method of treating ovarian cancer in a female human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a ovarian cancer treatment method that includes administering 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2- pyrimidinyl]amino]-2-methylbenzenesulfonamide, or a pharmaceutically acceptable salt thereof, and 2-[(5-chloro-2-[[3-methyl-1-(1-methylethyl)-1 H-pyrazol-5-yl]amino]-4- pyridinyl)amino]-N-methoxybenzamide, or a pharmaceutically acceptable salt thereof, and optionally 1,7β,10β-trihydroxy-9-oxo-5β,20-epoxytax-11-ene-2α,4, 13α-triyl 4- acetate 2-benzoate 13-{(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3- phenylpropanoate}, to a human in need thereof.
Patent WO-2017151054-A1 (WO)
Title: Machine de maintenance de presse continue
Inventor: THAM CHEK CHUNG
IPC: B30B9/12
Filed: 2017-02-02
Abstract: Une machine de maintenance d'une presse continue comprend un poste d'arrimage pour s'ajuster sur une presse continue, et un module en contact avec le sol accouplé au poste d'arrimage pour supporter le poste d'arrimage et transporter la presse continue sur le sol.
Patent WO-2019054948-A1 (WO)
Title: Emulsions, methods and uses thereof
Inventor: LI JIAN
IPC: B01J13/02
Filed: 2018-09-14
Abstract: The present disclosure relates to emulsions, methods of preparation thereof, and uses of said emulsions to fabricate porous polymeric microspheres as microcarriers for cell culture. In particular, the present disclosure relates to an emulsion with enhanced stability, characterized in that the emulsion comprises a) a water phase, the water phase is an aqueous solution comprising a salt; and b) an oil phase, the oil phase comprising a polymer; wherein the oil phase is immiscible with the water phase, and wherein the density differential of the water phase and oil phase is less than about 0.02 g/cm3. In a preferred embodiment, the polymer is polycaprolactone (PCL).
Patent WO-2019160508-A1 (WO)
Title: Method and apparatus for shearing tissue at a target surgical site
Inventor: BELKIN MICHAEL
IPC: A61F9/007
Filed: 2019-02-15
Abstract: A surgical tool for shearing tissue at a target surgical site, the surgical tool comprising a cannula assembly, a cannula opening into the lumen of the cannula assembly at a distal end, a cutting device coupled to the distal end and within the cannula opening, and an axial ball joint coupled to the proximal end of the cannula assembly, that when rotated, causes the cutting device to rotate about a longitudinal axis passing axially through the lumen of the cannula assembly, so as to shear a portion of tissue at a target surgical site. The target surgical site is a trabecular meshwork of an eye for treating glaucoma in a subject. Also disclosed is a surgical tool for shearing tissue comprising a cannula assembly with a flexible sheath attached to a cannula hub comprising a central inner hub hole and one or more outer hub holes coupled to the cannula assembly.
Patent WO-2020145899-A1 (WO)
Title: Capteur et système de surveillance et de gestion de la jaunisse néonatale
Inventor: TRAU DIETER WILHELM
IPC: G01N33/49
Filed: 2020-01-13
Abstract: La présente invention concerne un capteur pour surveiller des changements de taux sanguins de bilirubine. Le capteur de la présente invention comprend une ou plusieurs sources de lumière de blanchiment, une ou plusieurs sources de lumière de capteur et un ou plusieurs capteurs. Dans un mode de réalisation particulier, une source de lumière de blanchiment génère une lumière de blanchiment dans une plage de longueurs d'onde de 400 nm à 600 nm, et une source de lumière de capteur génère de la lumière dans une plage de longueurs d'onde de 400 nm à 600 nm, de préférence aux maxima d'absorbance de la bilirubine à 450 nm +/- 20 nm. La source de lumière de blanchiment est décolorante et photocatalytique, convertissant la bilirubine en isomères/dérivés solubles dans l'eau qui sont éliminés plus rapidement de la peau et sécrétés par le corps. Par conséquent, la bilirubine déposée est éliminée dans le trajet de lumière de la source de lumière de capteur, et le procédé non invasif de la présente invention permet de mesurer le taux sanguin de bilirubine sans interférence de la bilirubine déposée dans les tissus, par exemple la peau. Le capteur optique non invasif et le procédé peuvent être appliqués dans la surveillance de la progression de la jaunisse et pour gérer une photothérapie de la jaunisse.
Patent WO-2022139681-A1 (WO)
Inventor: TAN SOON HENG
IPC: G01N33/68
Filed: 2021-12-20
Abstract: L'invention concerne globalement le domaine de la biochimie. En particulier, l'invention concerne une méthode de détection ou de mesure d'une cible liée à un ligand dans un échantillon, la méthode consistant à mettre en contact un échantillon comprenant une ou plusieurs cellules avec un dénaturant à perméation cellulaire pour favoriser le dépliement intracellulaire de la cible dans l'échantillon avant la lyse de l'échantillon. Le niveau de cible non agrégée ou de cible agrégée de l'échantillon lysé est ensuite détecté ou mesuré, une différence du niveau de cible non agrégée ou de cible agrégée par rapport à une référence indiquant la présence ou le niveau de cible liée au ligand dans l'échantillon. Selon des modes spécifiques de réalisation, le dénaturant à perméation cellulaire est l'urée ou ses dérivés. La présente invention concerne également des méthodes d'identification d'un ligand candidat ou de prédiction de l'efficacité d'un médicament chez un sujet.
Patent WO-2012015364-A1 (WO)
Title: Système de voiles à profil plus épais
Inventor: PRIMOZ KUNAVER
IPC: B63H9/06
Filed: 2011-07-22
Abstract: Un système de voiles à profil plus épais résout le défi technique de conception de construction qui améliorera la portance aérodynamique et réduira la traînée aérodynamique et, en même temps, fonctionnera par des conditions météorologiques rigoureuses, permettra l'abaissement de la voile et n'entraînera qu'un poids supplémentaire mineur sur le mât. L'ensemble de la voile principale se compose de la partie avant de la voile principale (2), qui est montée à demeure sur le mât et de la partie arrière de la voile principale (6) qui peut être montée ou abaissée. Le mât (8) est monté à l'intérieur de la construction de voile au profil plus épais. L'ensemble de la voile avant est constitué d'une partie de textile de voile (10) à l'intérieur duquel est montée une latte tendue (14) qui donne la forme au profil plus épais.
Patent TN-2009000507-A1 (TN)
Title: Mould with mobile intermediate surface
Inventor: SENSINI ANDREA
IPC: A43B17/08
Filed: 2009-12-01
Abstract: The present invention concerns a mould divided into three parts for the direct moulding of a membrane equipped with a series of suction cups having the particular shape of an open hourglass or of bellows or of a cylinder onto a support made of breathable, waterproof or hydrophilic material positioned on the intermediate mobile part of the mould which is pressed against the lower part of the mould during the moulding phase and raised after moulding has been completed thanks to a series of springs that bring it back to its original position permitting automatic removal of the moulded suction cups without damage to their particular shape
Patent TN-2011000635-A1 (TN)
Title: Chaudiere a ionisaton
Inventor: ZOUHAIER LANDOULSI
IPC: F24H1/00
Filed: 2011-12-12
Abstract: chaudière a ionisation a très bas prix pour chauffer de l'eau a faible coups d'energie. L'innovation consiste principalement a fabriquer uen chaudière menagère ou industrielle (de 3 à 35kw par corps de chauffe et de plusieurs kw en utilisant plusieurs corsp de chauffe en parallèles). La chaudière est constituée principalement d'un corps de chauffe ionique (figure n° 01), d'une pompe circulateur (fig n°02), d'un echangeur de plaques (fig n° 03). Le liquide caloporteur se chauffe rapidement et une haute température par ionisation après avoir été excité par un champ electrique dans le coprs de chauffe (fig n° 07). Par les tubes d'aspiration de la pompe circulateur le liquide caloporteur passe du coprs de chauffe vers l'echangeur a plaque ou il dissipe ces calories vert le circuit secondaire ou circule le cops a chauffer. En fin, le liquide caloporteur rebrousse chemin vers le corps de chauffe et reprend des caloreis en s'echauffant. L'arret du corps de chauffe se fait par la programmation de la température de consigne de l'utilisateur et par une sonde de temperature de surchauffe et par un relais de limite de fonctionnement .
Patent WO-2012093981-A1 (WO)
Title: Élément structurel d'isolation thermique et phonique
Inventor: HAZAR ENGIN
IPC: E04C1/41
Filed: 2012-03-02
Abstract: La présente invention concerne un élément structurel qui est obtenu sous deux formes différentes (figure 1 et figure 8) à utiliser dans des procédés de formation de murs et qui peut être utilisé dans le secteur du bâtiment pour conférer une isolation thermique et phonique et une protection contre l'eau. Une partie inférieure d'une unité externe en EPS, XPS, polyuréthane, laine de roche, laine de verre, etc., est séparée selon des procédés de scission, de déchirure, de démontage pour permettre l'observation du béton sur les surfaces opposées du produit après le remplissage d'une boîte en EPS, XPS, polyuréthane, laine de roche, laine de verre, etc., avec un béton léger produit au moyen d'un agrégat (sable, gravillon, pierre cassée, etc.) et/ou d'un ciment et/ou de produits chimiques et le durcissement du béton. Ledit élément structurel est caractérisé en ce que quatre de ses six surfaces sont recouvertes d'un matériau isolant et, par conséquent, une liaison béton sur béton est obtenue lors d'un procédé de formation de mur.
Patent WO-2015105469-A1 (WO)
Title: Extrait de cerise acide avec capacite antioxydante accrue par 1,5 fois et son procede de production
Inventor: LE BELLOUR YANN
IPC: A23L5/20
Filed: 2015-01-05
Abstract: La présente invention concerne un extrait de cerise acide (sous forme de liquide ou de poudre) caractérisé en ce qu'il comporte: le concentré de cerise acide avec une valeur de 65 °Brix, de la levure de Saccharomyces cerevisiae, de la malodextrine et/ou de l'eau, destiné à être consommé sous forme de liquide ou de poudre.
Patent WO-2019132838-A1 (WO)
Title: Compositions pharmaceutiques de dabigatran
Inventor: TÜRKYILMAZ ALI
IPC: A61K31/4439
Filed: 2018-12-26
Abstract: La présente invention concerne des compositions pharmaceutiques destinées à être administrées par voie orale comprenant un noyau comprenant une base libre d'étéxilate de dabigatran ou un sel pharmaceutiquement acceptable d'étéxilate de dabigatran et une couche de séparation et une couche acide.
Patent WO-2021154184-A1 (WO)
Title: Hydraulic actuator for controlling flexion and extension speed of the prosthetic knee joint
Inventor: SAHIN ILHAN
IPC: A61F2/66
Filed: 2021-01-27
Abstract: The invention enables to control with manual adjustment elements (6) the flexion and extension speeds that are movements of the prosthetic knee joint using a speed and direction control mechanism (10). Thereby a controllable artificial knee joint can be created.
Patent WO-2022115062-A1 (WO)
Inventor: GENÇ MEHMET HAYRI
IPC: B32B15/08
Filed: 2021-04-20
Abstract: La présente invention concerne une structure stratifiée comportant au moins un film métallisé, qui est appropriée pour des applications d'impression et de découpe, et utilisée pour des procédés de moulage par injection en tant que film d'étiquette. Une étiquette pour moulage en moule comprend un film stratifié (1) comprenant un film métallisé multicouche (10) et un film multicouche (20), assemblés par une couche adhésive (30). Le film métallisé multicouche (10) est un film polymère comprenant une couche externe de film métallisé multicouche (101), une couche de revêtement métallisable de film métallisé multicouche (103) contenant des ingrédients actifs organiques ou inorganiques à l'intérieur de la matrice polymère à raison de 500 à 7 500 ppm, une couche centrale de film métallisé multicouche (102), une couche métallique (104). Le film multicouche (20) est un film polymère comprenant une couche stratifiée (201), une couche centrale de film multicouche (202) et une couche externe de film multicouche (203).